Domov › Rak jajčnikov › Connecticut

Klinične študije za Rak jajčnikov v Connecticut

28 študij za Rak jajčnikov išče udeležence na lokacijah v Connecticut.

Mesta v Connecticut

Uradno besedilo študije (angleško)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Yale Cancer Center, New Haven

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Yale Cancer Center, New Haven

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Yale University - Yale University School of Medicine, New Haven

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07360314

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Site 0158 - Hartford HealthCare, Hartford

Vključevanje udeležencevFaza 2

Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT05128825

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Danbury Hospital, Western Connecticut Health Network /ID# 274783, Danbury
Yale University School of Medicine /ID# 275794, New Haven
Norwalk Hospital /ID# 274561, Norwalk

Vključevanje udeležencevFaza 2

Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT06890338

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, New Haven

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05867251

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, New Have

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07229313

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

UConn Health, Farmington

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213804

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Yale University, Yale Cancer Center, New Haven

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05983432

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

Yale Cancer Center, New Haven

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06303505

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0001), New Haven

Vključevanje udeležencevFaza 3

Starost 18 in več · Ženske · Posodobljeno 3. sep. 2026 · NCT06824467

Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

Danbury Hospital, Danbury

Vključevanje udeležencevFaza 3

Starost 18 in več · Ženske · Posodobljeno 1. sep. 2026 · NCT07564141

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Greenwich, Greenwich
in še 8

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT07001748

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Normunity Investigational Site, New Haven

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07182149

A Study of PHST001 in Advanced Solid Tumors

Yale Cancer Center, New Haven

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT06840886

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Danbury Hospital, Danbury
Smilow Cancer Hospital Care Center at Greenwich, Greenwich
Hartford Hospital, Hartford
in še 5

Vključevanje udeležencev

Starost 35–50 · Ženske · Posodobljeno 7. avg. 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Danbury Hospital, Danbury
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Greenwich, Greenwich
in še 8

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06580314

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Yale University School of Medicine, New Haven

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT06161025

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Norwalk Hospital, Norwalk

Vključevanje udeležencevFaza 2

Starost 8 in več · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT05503797

Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer

Yale University, New Haven

Vključevanje udeležencev

Starost 18 in več · Ženske · Posodobljeno 20. jul. 2026 · NCT05761561

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

Yale University, New Haven

Vključevanje udeležencevFaza 1

Starost 18 in več · Ženske · Posodobljeno 6. jul. 2026 · NCT07226427

Integrated Cancer Repository for Cancer Research

Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Yale University, Yale Cancer Center, New Haven

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT06993844

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Hartford Hospital, Hartford
Smilow Cancer Hospital at Yale- New Haven, New Haven
Yale University School of Medicine, New Haven

Vključevanje udeležencevFaza 3

Starost 18 in več · Ženske · Posodobljeno 16. apr. 2026 · NCT05659381

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Yale University, Yale Cancer Center, New Haven

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT06395519

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

Yale University, New Haven

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 14. jan. 2026 · NCT06234423

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Smilow Cancer Hospital at Yale - New Haven, New Haven

Vključevanje udeležencevFaza 2

Starost 18 in več · Ženske · Posodobljeno 23. dec. 2025 · NCT06690775

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Hartford
Massive Bio SYNERGY-AI site, Norwalk

Vključevanje udeležencevOpazovalna študija

Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.